Maternus-Kliniken Aktiengesellschaft (MAK.DE)
EUR 1.49
(-2.61%)
EUR 1.49
(-2.61%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 586 Thousand EUR | 0.0% |
| 2022 | 586 Thousand EUR | -2.01% |
| 2021 | 598 Thousand EUR | 34.68% |
| 2020 | 444 Thousand EUR | -1.11% |
| 2019 | 449 Thousand EUR | -11.44% |
| 2018 | 507 Thousand EUR | 16.02% |
| 2017 | 437 Thousand EUR | 0.69% |
| 2016 | 434 Thousand EUR | 0.46% |
| 2015 | 432 Thousand EUR | 11.05% |
| 2014 | 389 Thousand EUR | -4.19% |
| 2013 | 406 Thousand EUR | 3.05% |
| 2012 | 394 Thousand EUR | 3.41% |
| 2011 | 381 Thousand EUR | -8.41% |
| 2010 | 416 Thousand EUR | 7.77% |
| 2009 | 386 Thousand EUR | 0.52% |
| 2008 | 384 Thousand EUR | 0.0% |
| 2007 | 384 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 586 Thousand EUR | 0.0% |
| 2023 Q2 | 586 Thousand EUR | 0.0% |
| 2023 Q3 | 586 Thousand EUR | 0.0% |
| 2023 FY | 586 Thousand EUR | 0.0% |
| 2023 Q4 | 586 Thousand EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q4 | 586 Thousand EUR | 0.0% |
| 2022 Q3 | 586 Thousand EUR | -2.01% |
| 2022 Q2 | 598 Thousand EUR | 0.0% |
| 2022 FY | 586 Thousand EUR | -2.01% |
| 2021 Q4 | 708 Thousand EUR | 18.39% |
| 2021 Q3 | 598 Thousand EUR | 34.99% |
| 2021 FY | 598 Thousand EUR | 34.68% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q2 | 443 Thousand EUR | 0.0% |
| 2020 Q3 | 444 Thousand EUR | -0.67% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 447 Thousand EUR | 0.0% |
| 2020 FY | 444 Thousand EUR | -1.11% |
| 2020 Q4 | 472 Thousand EUR | 6.31% |
| 2019 Q3 | 449 Thousand EUR | -10.91% |
| 2019 FY | 449 Thousand EUR | -11.44% |
| 2019 Q2 | 504 Thousand EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q4 | 449 Thousand EUR | 0.0% |
| 2018 Q4 | 507 Thousand EUR | 0.0% |
| 2018 Q3 | 507 Thousand EUR | 15.49% |
| 2018 Q2 | 439 Thousand EUR | 0.0% |
| 2018 FY | 507 Thousand EUR | 16.02% |
| 2018 Q1 | - EUR | -100.0% |
| 2017 Q3 | 437 Thousand EUR | 0.46% |
| 2017 Q4 | 437 Thousand EUR | 0.0% |
| 2017 Q2 | 435 Thousand EUR | 0.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 FY | 437 Thousand EUR | 0.69% |
| 2016 Q4 | 434 Thousand EUR | 0.0% |
| 2016 FY | 434 Thousand EUR | 0.46% |
| 2016 Q3 | 434 Thousand EUR | 0.93% |
| 2016 Q2 | 430 Thousand EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2015 Q2 | 383 Thousand EUR | 1.59% |
| 2015 Q3 | 380 Thousand EUR | -0.78% |
| 2015 Q4 | 432 Thousand EUR | 13.68% |
| 2015 FY | 432 Thousand EUR | 11.05% |
| 2015 Q1 | 377 Thousand EUR | -3.08% |
| 2014 Q4 | 389 Thousand EUR | -2.99% |
| 2014 Q1 | - EUR | -100.0% |
| 2014 FY | 389 Thousand EUR | -4.19% |
| 2014 Q2 | 405 Thousand EUR | 0.0% |
| 2014 Q3 | 401 Thousand EUR | -0.99% |
| 2013 Q3 | 389 Thousand EUR | -1.27% |
| 2013 FY | 406 Thousand EUR | 3.05% |
| 2013 Q2 | 394 Thousand EUR | 4.23% |
| 2013 Q1 | 378 Thousand EUR | -4.06% |
| 2013 Q4 | 406 Thousand EUR | 4.37% |
| 2012 Q2 | 382 Thousand EUR | 0.26% |
| 2012 Q1 | 381 Thousand EUR | 0.0% |
| 2012 FY | 394 Thousand EUR | 3.41% |
| 2012 Q4 | 394 Thousand EUR | 2.6% |
| 2012 Q3 | 384 Thousand EUR | 0.52% |
| 2011 FY | 381 Thousand EUR | -8.41% |
| 2011 Q3 | 414 Thousand EUR | -0.96% |
| 2011 Q2 | 418 Thousand EUR | 3.72% |
| 2011 Q4 | 381 Thousand EUR | -7.97% |
| 2011 Q1 | 403 Thousand EUR | -3.13% |
| 2010 Q4 | 416 Thousand EUR | 0.0% |
| 2010 FY | 416 Thousand EUR | 7.77% |
| 2009 FY | 386 Thousand EUR | 0.52% |
| 2008 FY | 384 Thousand EUR | 0.0% |
| 2007 FY | 384 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 2.17 Billion EUR | 99.973% |
| Fresenius SE & Co. KGaA | 2.51 Billion EUR | 99.977% |
| LIMES Schlosskliniken AG | 80.12 Thousand EUR | -631.339% |
| M1 Kliniken AG | 45.52 Million EUR | 98.713% |
| MEDICLIN Aktiengesellschaft | 7.29 Million EUR | 91.969% |
| RHÖN-KLINIKUM Aktiengesellschaft | 34.21 Million EUR | 98.287% |
| VITA 34 AG | 3.4 Million EUR | 82.79% |